https://assurance-maladie.ameli.fr/etudes-et-donnees/2024-vedolizumab-ustekinumab-anti-tnf-grossesse-mici 2024 France scientific and technical information safety TNF Gene Ustekinumab inflammatory bowel disease, nos tumor necrosis factor Institutional Review Board Independent Ethics Committee Notification of Safety Information
Documentation Physically Feel in Bad Condition tumor necrosis factors Safety Report Clinical Trial Notification of Safety or Other Trial Information Documentation chronic disease, nos Vedolizumab research report vedolizumab disease Tumor Necrosis Factor anti-TNF Ustekinumab Chronic Disease Pregnant People inflammatory bowel diseases vedolizumab pregnancy, nos albumin/globulin ratio chronic disease Gravida